Last reviewed · How we verify

NCT04295473

Reduced Port Laparoscopic Gastrectomy for Gastric Cancer

Recruiting now NA Last updated 21 May 2025
What this trial tests

NA trial testing Reduced port laparoscopic gastrectomy in Laparoscopic in 160 participants. Currently enrolling.

Timeline
2 March 2020
Primary endpoint
1 March 2027
1 March 2027

Quick facts

Lead sponsorNanchong Central Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment160
Start date2 March 2020
Primary completion1 March 2027
Estimated completion1 March 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Nanchong Central Hospital

Who can join

Adults 18 to 90, any sex, with Laparoscopic or Gastrectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Reduced port laparoscopic gastrectomy has been adopted in clinical. The safety and outcome of reduced port laparoscopic gastrectomy has not been systematically evaluated. The investigators sought to compare the short and long-term outcome of patients with gastric cancer who underwent reduced port gastrectomy with patients underwent traditional laparoscopic gastrectomy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Laparoscopic

Currently open trials in the same condition.

Other Nanchong Central Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04295473.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing